Peter Wimmer, country manager of Angelini Austria and Germany, discusses the tailored long-term strategy that this exciting Italian pharmaceutical company is implementing to establish a boutique portfolio and the importance of scientific data in constructing positive relationships throughout the healthcare community. Furthermore, he highlights the reasons Austria is being addressed as Angelini’s home to move into the German market and points-out the future growth potential of the company.
What was your goal when taking over the country manager role in 2010?
"The private market still has a great potential to grow, thus for us this sector has still a large growth potential in the already well developed Austrian healthcare system."
